Appearance and disappearance of neutralizing antibodies during interferon-beta therapy
Research output: Contribution to journal › Journal article › Research › peer-review
Neutralizing antibodies (NABs) occur frequently in patients receiving interferon (IFN)-beta for multiple sclerosis (MS), but it is unclear whether occurrence of NABs is predictive for the persistence of NABs during continued IFN-beta therapy.
| Original language | English |
|---|---|
| Journal | Neurology |
| Volume | 65 |
| Issue number | 1 |
| Pages (from-to) | 33-9 |
| Number of pages | 7 |
| ISSN | 0028-3878 |
| DOIs | |
| Publication status | Published - 12 Jul 2005 |
ID: 34102301